| [1]STONE J H,ZEN Y,DESHPANDE V.IgG4-related disease[J].N Engl J Med,2012,366(6):539-551.
[2]UMEHARA H,OKAZAKI K,MASAKI Y,et al.A novel clinical entity,IgG4-related disease (IgG4-RD):general concept and details[J].Mod Rheumatol,2012,22(1):1-14.
[3]CORNELL L D.IgG4-related kidney disease[J].Semin Diagn Pathol,2012,29(4):245-250.
[4]GLASSOCK R J.Diagnosis and natural course of membranous nephropathy[J].Semin Nephrol,2003,23(4):324-332.
[5]DOI T,MAYUMI M,KANATSU K,et al.Distribution of IgG subclasses in membranous nephropathy[J].Clin Exp Immunol,1984,58(1):57-62.
[6]SAEKI T,NISHI S,IMAI N,et al.Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis[J].Kidney Int,2010,78(10):1016-1023.
[7]ZEN Y,FUJII T,HARADA K,et al.Th2 and regulatory immune reaction are increased in immunoglobulin G4-related sclerosing pancreatitis and cholangitis[J].Hepatology,2007,45(6):1538-1546.
[8]NAKASHIMA H,MIYAKE K,MORIYAMA M,et al.An amplification of IL-10 and TGF-beta in patients with IgG4-related tubulointerstitial nephritis[J].Clin Nephrol,2010,73(5):385-391.
[9]KAWAMURA E,HISANO S,NAKASHIMA H,et al.Immunohistological analysis for immunological response and mechanism of interstitial fibrosis in IgG4 related kidney disease[J].Mod Rheumatol,2015,5(4):571-578.
[10]KUROKI A,IYODA M,SHIBATA T,et al.Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy[J].Kidney Int,2005,68(1):302-310.
[11]黎磊石,刘志红.中国肾脏病学[M].北京:人民军医出版社,2008:387-388.
LI L S,LIU Z H.Kidney disease in China[M].Beijing:People’s Military Medical Press,2008:387-388.
[12]ALEXANDER M P,LARSEN C P,GIBSON I W,et al.Membranous glomerulonephritis is a manifestation of IgG4-related disease[J].Kidney Int,2013,83(3):455-462.
[13]HOGAN S L,MULLER K E,JENNETTE J C,et al.A review of therapeutic studies of idiopathic membranous glomerulopathy[J].Am J Kidney Dis,1995,25(6):862-875.
[14]SHERMAN R A,DODELSON R,GARY N E,et al.Membranous nephropathy[J].J Med Soc N J,1980,77(10):649-652.
[15]NOEL L H,ZANETTI M,DROZ D,et al.Long-term prognosis of idiopathic membranous glomerulonephritis.Study of 116 untreated patients[J].Am J Med,1979,66(1):82-90.
[16]POLANCO N,GUTIERREZ E,COVARSI A,et al.Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy[J].J Am Soc Nephrol,2010,21(4):697-704.
[17]NACHMAN P H,JENNETTE J C,FALK R J.Brenner and Rector’s the kidney[M].9th.Philadelphia:Elsevier/Saunders,2012:1100-1191.
[18]KAWANO M,SAEKI T,NAKASHIMA H,et al.Proposal for diagnostic criteria for IgG4-related kidney disease[J].Clin Exp Nephrol,2011,15(10):615-626.
[19]RAISSIAN Y,NASR S H,LARSEN C P,et al.Diagnosis of IgG4-related tubulointerstitial nephritis[J].J Am Soc Nephrol,2011,22(7):1343-1352.
[20]HOUGHTON D C,TROXELL M L.An abundance of IgG4+ plasma cells is not specific for IgG4-related tubulointerstitial nephritis[J].Mod Pathol,2011,24(11):1480-1487.
[21]SCHWARTZ M M.Heptinstall’s pathologyof the kidney[M].6th.Philadelphia:Lippincott Williams & Wilkins,2007:205-252.
[22]BECK LH J R,BONEGIO R G,LAMBEAU G,et al.M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy[J].N Engl J Med,2009,361(1):11-21.
[23]HOXHA E,KNEIβLER U,STEGE G,et al.Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy[J].Kidney Int,2012,82(7):797-804.
[24]TOMAS N M,BECK LH J R,MEYER-SCHWESINGER C,et al.Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy[J].N Engl J Med,2014,371(24):2277-2287.
[25]HAAS M.IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies[J].Am J Kidney Dis,1994,23(3):358-364.
[26]KAMISAWA T,OKAZAKI Y,KAWA S,et al.Japanese consensus guidelines for management of autoimmune pancreatitis:Ⅲ.Treatment and prognosis of AIP[J].J Gastroenterol,2010,45(5):471-477.
[27]SAEKI T,KAWANO M,MIZUSHIMA I,et al.The clinical course of patients with IgG4-related kidney disease[J].Kidney Int,2013,84(4):826-833.
[28]YAMAMOTO M,TAKAHASHI H,TABEYA T,et al.Risk of malignancies in IgG4-related disease[J].Mod Rheumatol,2012,22(3):414-418.
[29]Chapter 7:Idiopathic membranous nephropathy[J].Kidney Int Suppl(2011),2012,2(2):186-197.DOI:10.1038/kisup.2012.20
[30]PONTICELLI C,ALTIERI P,SCOLARI F,et al.A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy[J].J Am Soc Nephrol,1998,9(3):444-450.
[31]CHEN M,LI H,LI X Y,et al.Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy:a multicenter randomized controlled trial[J].Am J Med Sci,2010,339(3):233-238. |